{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:43:56Z","timestamp":1776062636372,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Accurate assessment of complete clinical response following neoadjuvant chemoradiotherapy remains challenging, and radiological evaluation criteria established for this treatment modality may not be applicable to neoadjuvant immunotherapy (NIT). Currently, there are no published studies describing the ultrasound features of pathological complete response (pCR) in patients with microsatellite instability-high (MSI-H) rectal cancer following NIT. In this case series, we comparatively analyzed multimodal transrectal ultrasound (TRUS) features before and after NIT in three patients with MSI-H mid- to low-rectal cancer. Despite imaging findings suggestive of residual lesions, two patients achieved pCR as confirmed by postoperative pathology, and one patient had no definite atypical components identified on ultrasound-guided biopsy. Our preliminary observations suggest that multimodal TRUS features, including reduced lesion size, diminished vascularity, heterogeneous hypoenhancement with non-enhancing areas on contrast-enhanced ultrasound, and reduced stiffness on shear wave elastography, may serve as potential imaging indicators of pCR in patients with MSI-H mid- to low-rectal cancer. Ultrasound-guided biopsy may provide complementary diagnostic information for confirming pCR in cases with persistent imaging abnormalities.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1772953","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:45:21Z","timestamp":1776059121000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Ultrasound features of pathological complete response in middle and low rectal cancer with high microsatellite instability after neoadjuvant immunotherapy: a case series"],"prefix":"10.3389","volume":"17","author":[{"given":"Li","family":"Liang","sequence":"first","affiliation":[{"name":"Ultrasound Medical Center, The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]},{"name":"Department of Ultrasound, Gansu Provincial Hospital","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Gansu Provincial Hospital","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anorectal Surgery, Gansu Provincial Hospital","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Gansu Provincial Hospital","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Gansu Provincial Hospital","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Nie","sequence":"additional","affiliation":[{"name":"Ultrasound Medical Center, The Second Hospital and Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]},{"name":"Gansu Province Clinical Research Center for Ultrasonography","place":["Lanzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/nejmc2210175","article-title":"Prevalence of mismatch-repair deficiency in rectal adenocarcinomas","volume":"387","author":"Papke","year":"2022","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.00046","article-title":"Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial","volume":"41","author":"Morton","year":"2023","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0041","article-title":"NCCN guidelines\u00ae Insights: rectal cancer, version 3.2024","volume":"22","author":"Benson","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.05.528","article-title":"Localised rectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"36","author":"Hofheinz","year":"2025","journal-title":"Ann Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/s2468-1253(21)00348-4","article-title":"Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial","volume":"7","author":"Hu","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.7096","article-title":"Long-term outcomes of dMMR\/MSI-H rectal cancer treated with anti-PD-1-based immunotherapy as curative-intent treatment","volume":"22","author":"Yu","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103499","article-title":"Neoadjuvant PD-1 blockade with toripalimab with or without celecoxib for patients with mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): long-term outcomes of a single-centre, parallel-group, non-comparative, randomised phase 2 trial","volume":"88","author":"Shen","year":"2025","journal-title":"EClinicalMedicine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104921","article-title":"Immune checkpoint inhibitors for dMMR\/MSI localized rectal cancer: a systematic review of treatment strategies","volume":"215","author":"Petrelli","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.6004\/jnccn.2022.7071","article-title":"Prevalent pseudoprogression and pseudoresidue in patients with rectal cancer treated with neoadjuvant immune checkpoint inhibitors","volume":"21","author":"Xie","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000002795","article-title":"Applicability of cCR assessment criteria in pMMR rectal cancer patients treated with neoadjuvant chemoradiotherapy combined with immunotherapy","volume":"111","author":"Pei","year":"2025","journal-title":"Int J Surg"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-024-04792-8","article-title":"Combined transrectal ultrasound and radiomics model for evaluating the therapeutic effects of neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"40","author":"Abuliezi","year":"2025","journal-title":"Int J Colorectal Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12880-024-01237-0","article-title":"Development and validation of a multi-modal ultrasomics model to predict response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer","volume":"24","author":"Qin","year":"2024","journal-title":"BMC Med Imaging"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2174\/0115734056327323250108055841","article-title":"Evaluation of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer through shear-wave elastography","volume":"21","author":"Qian","year":"2025","journal-title":"Curr Med Imaging"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1340060","article-title":"Quantitative analysis of contrast-enhanced ultrasound in neoadjuvant treatment of locally advanced rectal cancer: a retrospective study","volume":"13","author":"Bai","year":"2023","journal-title":"Front Oncol"},{"key":"B18","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.913483","article-title":"Efficacy and safety of neoadjuvant monoimmunotherapy with PD-1 inhibitor for dMMR\/MSI\u2043H locally advanced colorectal cancer: a single-center real-world study","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.241664","article-title":"Organ preservation in rectal cancer: MRI and the watch-and-wait approach","volume":"312","author":"Milot","year":"2024","journal-title":"Radiology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-10645-3","article-title":"ESR essentials: Imaging in colorectal cancer-practice recommendations by ESGAR","volume":"34","author":"Caruso","year":"2024","journal-title":"Eur Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-012-2309-3","article-title":"Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer","volume":"19","author":"Patel","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221529","article-title":"Watch-and-wait approach to rectal cancer: the role of imaging","volume":"307","author":"Jayaprakasam","year":"2023","journal-title":"Radiology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.02525","article-title":"Prospective correlation of magnetic resonance tumor regression grade with pathologic outcomes in total neoadjuvant therapy for rectal adenocarcinoma","volume":"41","author":"Hall","year":"2023","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06565-2","article-title":"MR tumor regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy","volume":"30","author":"Jang","year":"2020","journal-title":"Eur Radiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae027","article-title":"Can rectal MRI and endorectal ultrasound accurately predict the complete response to neoadjuvant immunotherapy for rectal cancer","volume":"12","author":"Zhai","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.11152\/mu-4375","article-title":"The correlation between time-intensity curve parameters of transrectal contrast-enhanced ultrasound and pathological prognostic factors in rectal adenocarcinoma","volume":"26","author":"Su","year":"2024","journal-title":"Med Ultrason"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.70071","article-title":"Predicting efficacy of neoadjuvant chemoradiotherapy for locally advanced rectal cancer using transrectal contrast-enhanced ultrasound-based radiomics model","volume":"54","author":"Liao","year":"2026","journal-title":"J Clin Ultrasound"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-024-04361-1","article-title":"Shear-wave elastography predicts T-restaging and pathologic complete response of rectal cancer post neoadjuvant chemoradiotherapy","volume":"49","author":"Qian","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/jum.15378","article-title":"Application value of shear wave elastography in the evaluation of tumor downstaging for locally advanced rectal cancer after neoadjuvant chemoradiotherapy","volume":"40","author":"Cong","year":"2021","journal-title":"J Ultrasound Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1402498","article-title":"A prospective study on using shear wave elastography to predict the ypT0 stage of rectal cancer after neoadjuvant therapy: a new support for the watch-and-wait approach","volume":"11","author":"Liu","year":"2024","journal-title":"Front Mol Biosci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000001152","article-title":"Evaluation of transrectal ultrasound-guided tru-cut biopsy as a complementary method for predicting pathological complete response in rectal cancer after neoadjuvant treatment: a phase II prospective and diagnostic trial","volume":"110","author":"Huang","year":"2024","journal-title":"Int J Surg"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/dcr.0b013e31827541e2","article-title":"Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer","volume":"56","author":"Duldulao","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-011-1348-8","article-title":"Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy","volume":"27","author":"Kuo","year":"2012","journal-title":"Int J Colorectal Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.19538\/j.cjps.issn1005-2208.2023.01.13","article-title":"Annual report of Chinese colorectal cancer surgery database in 2022: a nationwide registry study","volume":"43","author":"Yao","year":"2023","journal-title":"Chin J Pract Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2018.06.031","article-title":"A meta-analysis of the prevalence of low anterior resection syndrome and systematic review of risk factors","volume":"56","author":"Croese","year":"2018","journal-title":"Int J Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-023-10517-9","article-title":"Permanent stoma rate and long-term stoma complications in laparoscopic, robot-assisted, and transanal total mesorectal excisions: a retrospective cohort study","volume":"38","author":"Burghgraef","year":"2024","journal-title":"Surg Endosc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00538-5","article-title":"International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer","volume":"18","author":"Fokas","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0315339","article-title":"CLIP-based multimodal endorectal ultrasound enhances prediction of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer","volume":"19","author":"Zhang","year":"2024","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1772953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:45:23Z","timestamp":1776059123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1772953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2026.1772953"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1772953","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1772953"}}